Welcome to On-line version of the Prevention & Therapies for Hepatitis and Chronic Liver Disease Seminars 2024.  The content represents the most up-to-date information on the diagnosis and treatment of viral hepatitis and chronic liver disease. Your faculty are leading hepatologists from across the country.

The educational content resides on our digital app and you will be provided log-on information and credentials. When you have completed the course work, you will be directed to a site to take the required CME quiz, evaluate the seminar, and request your Continuing Education credits.

Target Audience
Gastroenterologists, Internists, Hepatologists, family physicians, clinical pharmacists as well as related advanced-practice clinicians and nurse specialists. 

Joint Provider Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville and SC Liver Research Consortiun. The University of Louisville is accredited by the ACCME to provide continuing education for physicians.


Designation Statement
The University of Louisville Office of Continuing Medical Education & Professional Development designates this enduring material for a maximum of 10.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses - This program has been approved by the Kentucky Board of Nursing for 12.6 continuing education credits through University of Louisville Hospital, provider number 4-0068-12-24-1385. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Completion criteria to obtain CE's: Attend entire session and complete the evaluation.

Course Instructions 
This online CME activity has been developed by the University of Louisville School of Medicine in joint providership with SC Liver Research Consortia. During the course you will watch and listen to a series of 16 video presentations. You will have to register and create a user profile before you are able to download the digital app and view the video material. Once the material has been viewed, you will take a brief post-activity test followed by a course evaluation, after which you will be able to generate your CME/CE certificate.

Accreditation Disclosure
As a provider accredited by the ACCME, the Office of CME&PD, School of Medicine, University of Louisville, must ensure balance, independence, objectivity, and scientific rigor in all its accredited educational activities. All Planners, faculty, reviewers, and other persons that affected the content of this CME activity were required to submit a financial disclosure form from which relevant conflicts of interest were determined. If any relevant financial relationship(s) with ineligible companies were disclosed, the materials each of them prepared for this program (or influenced) were peer-reviewed and determined to be without ineligible company bias, were considered fair and balanced in terms of therapeutic options, and presented evidence-based content. All relevant financial relationships with ineligible organizations have been mitigated prior to this activity.

Paul Pockros, MD - Course Director, Planner, Faculty; Speaking Fees: Intercept; Consulting Fees: AbbVie, GSK, Gilead, Intercept, Altimmune, Boston Pharmaceuticals, Antios Therapeutics, f5 Therapeutics; Grant/Contracted Research: Intercept, Gilead, Chemomab.
Howard J, Horwitz, MPH - Course Coordinator, Planner; has no relevant financial relationships to disclose.
Jacqueline O’Leary, MD - Consulting Fees: Genfit, Gilead, Abbvie, Mallinckrodt, Cellaion, Novo Nordisk; Stock Shareholder dividends: CVS.
Craig McClain, MD - Consulting Fees: Intercept; Grant/Contracted Research Fees/Funding: VAMC, Target Pharma, Altimmune.
Amit Singal, MD - Consulting Fees: Bayer, FujiFilm  Exact Sciences, Universal Dx, Glycotest, Roche, Freenome, Delfi, GRAIL, Genentech, AstraZeneca, Eisai, Exelixis, Boston Scientific, Sirtex, and HistoSonics.
Julio Gutierrez, MD - Speaking Fees: Gilead, Abbvie; Consulting Fees: Gilead, Abbvie.
Sidney Barritt, MD - Consulting Fees: Target RWE, Merck, Abbot Molecular.
Kirti Shetty, MD - Grant/Contracted Research Fees/Funding: Glycotest, HANMI-TRIA, Durect, Ocera-Biolet, Glocogen.
Paul Martin, MD - Consulting Fees: Ocelot; Grant/Contracted Research Fees/Funding: Seral Trial, Vikings, Enanta, EMD Serono.
Kathy Vincent, MD - Content Reviewer; has no relevant financial relationships to disclose.
Tracy Ander, DO - Content Reviewer; has no relevant financial relationships to disclose. 
The University of Louisville CME & PD Advisory Board and Office Staff have nothing to disclose with the following Board Member exceptions: Sathya Krishnasamy, MD -  Novo Nordisk (Grant Funding); Michael Sowell, MD – Amgen, Abbvie, Biohaven, Teva, Lundbeck (Speaking fees); Rainer Lenhardt, MD - CSL, Behring (Speaking Fees).

Hardware & Software Requirements
High speed internet connection
Browser: Google Chrome is recommended

Original Release & Termination Dates
Course Originally Released On: 3/10/2024
Date of Most Recent Review: 3/10/2024
Course Termination Date: 3/10/2026

Special Services
If you need special accommodations due to a disability, or for an alternative form of course materials, please contact Howard Horwitz. Continuing Medical Education & Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.

Provider Contact Information
If you need technical support or have questions about the course, please e-mail us at cmepd@louisville.edu

Privacy Policy Learner Consent Statement
Names or contact information of learners will not be shared with any ineligible company or its agents without the explicit consent of the individual learner.

Copyright
The University of Louisville has obtained permission to use the content in this educational activity.

Disclosure of Support from Ineligible Companies
This Internet Activity Enduring Material is Supported by educational grants from CymaBay, Intercept, Mallinckrodt, Salix, and Madrigal.

Course Learning Objectives
As a result of participating in this activity, participants should be able to:
1. Review the history, epidemiology, demographics, natural history, immunology, and pathophysiology that leads to increased incidence of viral hepatitis.
2. Explain the growth in Hepatitis D cases and new therapies to treat the disease.
3. Formulate and implement strategies for preventing, diagnosing, treating, and/or referring patients with viral hepatitis.
4. Implement the newest guidance and diagnostic algorithms  for portal hypertension.
5. Summarize the leading causes of the progression of chronic liver disease, hepatorenal syndrome, ascites, and hepatic encephalopathy.
6. Discuss the growing lists of First- and Second-Line therapies for liver cancer.
7. Explore the causes and impact of alcohol on liver health and progression toward malnutrition, cirrhosis, and liver cancer.
8. Integrate newer treatment options for HCC approaches to reduce tumor size and number.
9. Review the current therapies for PBC and clinical approaches for PSC.
10. Discover the pathway and barriers to liver disease elimination and the unique challenges of special populations.
11. Implement the new Fatty Liver Disease naming conventions in clinical practice.
12. Identify the reasons MASLD and MASH are fast becoming a global health emergency.
13. Utilize current clinical cases to improve diagnostic and treatment skills.
14. Evaluate the latest updates and scientific breakthrough from the 2023 EASL, DDW and AASLD conferences.
15. Improve the health of patients infected with hepatitis virus, liver cancer and other progressive liver diseases.

Registration

Fees
1. Physicians and Clinical Pharmacists - $95
2. Nurses, Nurse Practitioners and PAs - $70
3. Medical Residents & Fellows - $50
4. All Others - $95

TO REGISTER AND BEGIN THE COURSE   CLICK HERE

After you complete your registration,  an email confirmation will be sent. It has a "Click Here for App instructions" link leading to instructions on how to download the digital app and view the presentation material. Be sure to save the email and password you developed when you registered and paid for this course. After watching all the presentations, you will have to login again to complete the post-test, evaluation, and generate your Continuing Education certificate.

Content Questions and Comments
All participants are invited to submit their questions or comments about the content or cases in the presentations to cme@scliver.com
Questions will be routed one of the faculty experts for reply and each will be answered within 48 hours of receipt.

Attendee Cancellation, Substitution, Refund Policy
The course tuition is refundable, minus a $20 processing fee, if your cancellation is received prior to accessing the course content in the digital app. No refunds or credits will be given after the course materials are accessed.